Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Effects
16%
Aldosterone
16%
Aldosterone Levels
16%
Angiotensin II (Ang II)
33%
Angiotensin II Type 1 Receptor (AT1R)
16%
Autonomic Failure
100%
Blood Pressure
33%
Eplerenone
83%
Hypertension
66%
Mineralocorticoid
16%
Mineralocorticoid Receptor
16%
Mineralocorticoid Receptor Antagonists
16%
Multiple System Atrophy
16%
Nocturia
16%
Orthostatic Hypotension
16%
Parkinson's Disease
16%
Placebo
66%
Plasma Aldosterone Concentration
16%
Plasma Renin Activity
16%
Pure Autonomic Failure
16%
Randomized Double-blind Crossover Study
16%
Renin-angiotensin
16%
Supine Blood Pressure
16%
Supine Hypertension
100%
Systolic Blood Pressure
16%
Urine Volume
16%
Weight Loss
16%
Pharmacology, Toxicology and Pharmaceutical Science
Aldosterone
28%
Angiotensin
14%
Angiotensin 1 Receptor
14%
Angiotensin II
28%
Autonomic Dysfunction
100%
Eplerenone
71%
Hypertension
100%
Mineralocorticoid
14%
Mineralocorticoid Antagonist
14%
Mineralocorticoid Receptor
100%
Nocturia
14%
Orthostatic Hypotension
14%
Parkinson's Disease
14%
Placebo
57%
Pure Autonomic Failure
14%
Renin
28%
Shy Drager Syndrome
14%
Neuroscience
Aldosterone
28%
Angiotensin
14%
Angiotensin II
28%
Angiotensin II Receptor Type 1
14%
Blood Plasma
28%
Crossover Study
14%
Hypertension
100%
Hypotension
14%
Mineralocorticoid
14%
Mineralocorticoid Receptor
100%
Multiple System Atrophy
14%
Parkinson's Disease
14%
Placebo
57%
Plasma Renin Activity
14%
Receptor Antagonist
14%
Renin
14%